Digestive and Liver Disease · Published 2026-08-01 · DOI 10.1016/j.dld.2026.07.013
Yupeng Li, Yiming Mu, Fengxue Li, Jiandong Zhang, Jingxin Zhang, Lili Qiao, Yamin Zhang
PubPorta does not have an abstract for this article yet.
Read the article at the publisher →
Li, Y., Mu, Y., Li, F., et al. (2026). Patterns of progression and efficacy of immune checkpoint inhibitors in unresectable, recurrent, or metastatic cholangiocarcinoma: A real-world study. Digestive and Liver Disease. https://doi.org/10.1016/j.dld.2026.07.013